Treatment with sivelestat sodium of acute respiratory distress syndrome induced by chemical pneumonitis: A report of three cases.
acute respiratory distress syndrome
aspiration
chemical pneumonitis
pulmonary infection
sivelestat sodium
Journal
Experimental and therapeutic medicine
ISSN: 1792-1015
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
22
04
2023
accepted:
27
07
2023
medline:
27
9
2023
pubmed:
27
9
2023
entrez:
27
9
2023
Statut:
epublish
Résumé
Inhalation of acid fumes and aspiration of liquid substances or gastric contents may not initiate dyspnea within several hours after exposure but may result in delayed onset of alveolar edema. The present report presents three cases of inhalation or aspiration of chemical substances that resulted in acute respiratory distress syndrome (ARDS). Due to different underlying reasons, three patients developed ARDS resulting from chemical pneumonitis and pulmonary infection. From patients with dyspnea, dry rales could be heard in both lungs, with <92% percutaneous oxygen saturation at room air. All patients were treated using a high-flow nasal cannula and sivelestat sodium. Oxygenation gradually improved and the patients were discharged without adverse events. These cases suggest that early treatment with sivelestat sodium may improve the clinical outcomes of patients with ARDS.
Identifiants
pubmed: 37753302
doi: 10.3892/etm.2023.12175
pii: ETM-26-4-12175
pmc: PMC10518657
doi:
Types de publication
Case Reports
Langues
eng
Pagination
476Informations de copyright
Copyright: © Jing et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Occup Med (Lond). 2001 Jun;51(4):294-5
pubmed: 11463875
J Assoc Physicians India. 2011 Feb;59:115-7
pubmed: 21751650
N Engl J Med. 2019 Feb 14;380(7):651-663
pubmed: 30763196
Tuberc Respir Dis (Seoul). 2016 Oct;79(4):214-233
pubmed: 27790273
Oncotarget. 2017 Nov 28;9(2):1772-1784
pubmed: 29416730
Intensive Care Med. 2012 Oct;38(10):1573-82
pubmed: 22926653
New Horiz. 1993 Aug;1(3):435-9
pubmed: 7922422
N Engl J Med. 2006 Apr 20;354(16):1671-84
pubmed: 16625008
J Crit Care. 2015 Feb;30(1):40-8
pubmed: 25129577
Med Hypotheses. 2020 Nov;144:110005
pubmed: 32575019
Drug Des Devel Ther. 2013 Apr 10;7:305-16
pubmed: 23596346
Eur J Emerg Med. 2008 Dec;15(6):348-50
pubmed: 19078840
Clin Toxicol (Phila). 2013 Jun;51(5):385-93
pubmed: 23697460
Am J Respir Crit Care Med. 2003 Jun 15;167(12):1650-4
pubmed: 12689848
Biomolecules. 2021 Jul 21;11(8):
pubmed: 34439732
Monaldi Arch Chest Dis. 2011 Jun;75(2):135-7
pubmed: 21932699
N Engl J Med. 2001 Mar 1;344(9):665-71
pubmed: 11228282
Intern Med. 2009;48(3):129-35
pubmed: 19182422
Lung India. 2009 Oct;26(4):149-51
pubmed: 20532002
Ther Clin Risk Manag. 2014 Aug 05;10:621-9
pubmed: 25120368
Am J Respir Crit Care Med. 2017 Mar 15;195(6):725-736
pubmed: 28040987
Curr Opin Infect Dis. 2019 Apr;32(2):152-157
pubmed: 30676341
Indian J Occup Environ Med. 2018 Jan-Apr;22(1):54-56
pubmed: 29743787
Inj Prev. 2019 Feb;25(1):47-51
pubmed: 29691315
Acute Crit Care. 2021 Nov;36(4):395-396
pubmed: 34784455
Hum Exp Toxicol. 2007 Sep;26(9):697-703
pubmed: 17984140
Nat Rev Dis Primers. 2019 Mar 14;5(1):18
pubmed: 30872586
BMC Pulm Med. 2017 Nov 21;17(1):148
pubmed: 29162066
J Emerg Med. 2010 Jul;39(1):39-43
pubmed: 18842383
Int J Environ Res Public Health. 2017 Nov 17;14(11):
pubmed: 29149019
Cleve Clin J Med. 1997 Jul-Aug;64(7):365-72
pubmed: 9223766
J Assoc Physicians India. 2011 May;59:314
pubmed: 21751609